The comprehensive analysis of global Antipsychotic Drugs market provides an overview of the market and its key concerns. Market segmentation is concentric towards product distribution trends of each segment that would be helpful to strategist in deciding on the market segments. Market dynamics covers market drivers, restrains and opportunities, which would help to understand the market behaviour. Porter’s Five Forces analysis would be helpful in determining the market profitability. Buyers bargaining power is high for global antipsychotic drugs market due to patent expiration of major brands and availability of many generic medicines in the marketplace. Global antipsychotic drugs market has high threat from new entrants as major brands have lost their patent protection in 2012. Industrial rivalry is intense due to entry of numerous generic competitors, which forces big players to manipulate their drug prices according to changing market trends.
The key players within global antipsychotic drugs market include Eli Lilly, AstraZeneca, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline and Johnson & Johnson. Patent expiration of major brands such as Zyprexa (by Eli Lilly) and Seroquel (by AstraZeneca) has negatively impacted the total revenue of this maket. Generic competition is soaring due to patent expiration of six largest antipsychotic drugs in 2012.
Get Free Sample Report Of Antipsychotic Drugs Market @ http://www.marketresearchstore.com/report/world-antipsychotic-drugs-market-opportunities-and-forecasts-68521#RequestSample
Antipsychotic drugs are also termed as major tranquilizers or neuroleptics and these are primarily used to treat psychosis. The common psychotic disorders, where these drugs are majorly used include schizophrenia, hallucinations, delusions, bipolar disorder and others. The antipsychotic drugs market is expected to grow due to the rising number of Schizophrenic patients. However, patent expiration of major brands could negatively impact the market growth. Deep-dive analysis of global antipsychotic drugs market focuses on major market dynamics such as drivers, restrains and opportunities. Competitive landscape section profiles the key players on the basis of business performance, strategic moves and SWOT analysis. Profound analysis of segments would be helpful to understand the product distribution trends in each segment within the global antipsychotic drugs market.High prevalence of Schizophrenia and psychotic disorders are the prime drivers for global antipsychotic drugs market. Increased drug abuse, over prescription of drugs and addiction to antipsychotic drugs are the additional factors that drive the market growth for antipsychotic drugs. However, patent expiry of major brands over the past few years had negative impact on market growth and it has been responsible to the rising competition from generic drug manufacturer.
Do Inquiry To Buy Report Of Antipsychotic Drugs Market @ http://www.marketresearchstore.com/report/world-antipsychotic-drugs-market-opportunities-and-forecasts-68521#InquiryForBuying
MARKET BY BRANDS
- First Generation Drugs (Standard / Typical Antipsychotic Agents)
- Thorazine (Chlorpromazine HCl)
- Serentil (Mesoridazine Besylate)
- Mellaril (Thioridazine HCl)
- Haldol (Haloperidol)
- Clozaril (Clozapine)
- Invega (Paliperidone)
- Asendin (Amoxapine)
- Latuda (Lurasidone)
- Others
- Third generation Drugs
- Abilify (Aripiprazole)
MARKET BY APPLICATION
- Schizophrenia
- Bipolar Disorder
- Dementia
- Unipolar Depression
- Other
MARKET BY GEOGRAPHY
- North America
Contact Us:
Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: [email protected]
Web: http://www.marketresearchstore.com/
